Zobrazeno 1 - 5
of 5
pro vyhledávání: '"De Yi Lu"'
Autor:
Ke Ren Shen, Fahad Alzubi, Adrian Cheng, Alina Garcia Taormina, Brentt Ramsey, Faisal Aldhabib, Kelly Tovalin, Elias Ashe, Liang Zeng, Abdullah Alsumait, Martin Del Campo, Omar S. Es-Said, Xiao Dong Sun, De Yi Lu, Y. Li
Publikováno v:
Diffusion Foundations. 22:118-139
15-5PH stainless steel is widely used in the aerospace industry, from precision fuse pins to forged products, due to its various high-performance properties. However, there is little systematic evaluation of heat treatment responses, especially at ul
Publikováno v:
Journal of Cancer
Cytokines are vital mediators involved in tumor immunity. We aimed to explore whether the expression levels of IL-1β, TNF-α and IL-6 have impacts on prognosis of SCLC patients. In this study, we concluded 707 non-operable SCLC patients at stage III
Autor:
De-Yi Lu, Xu-Hua Mao, Hua Jiang, Weiping Wang, Yabiao Zheng, Wei-Liang Ding, Jianguo Wang, Juanjuan Xiao, Neetika Ashwani, Yan Shang, Minghua Wang, Ping Zhang, Yinghui Zhou, Xiao-Long Yan
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:5249-5252
Nogo protein, encoded by gene reticulon-4 (RTN4), includes three major isoforms by different splicing, named Nogo-A Nogo-B and Nogo-C. Nogo proteins play an important role in the apoptosis of cells, especially in tumor cells. RTN4 single nucleotide p
Autor:
Jianguo Wang, Yuzhen Gao, Juanjuan Xiao, Ping Zhang, De-Yi Lu, Junjie Zhang, Minghua Wang, Jianhua Che, Dong Jiang, Bin Zhu, Yabiao Zheng, Xiaolong Yan
Publikováno v:
Tumor Biology. 35:8921-8925
Hypoxia is a common phenomenon in the development of solid tumors, and hypoxia inducible factor 1 (HIF-1) plays a central role in coordinating the cellular response to hypoxia and in oxygen homeostasis. The prolyl hydrolase 1 (PHD1) is a key adjustme
Autor:
Xiao Ju Zhu Ge, Igor Longe Phemba, De Yi Lu, Zhi Ming Huang, Chang Yuan Hu, Ren Pin Chen, Guang Rong Lu, Xiao Hua Ye
Publikováno v:
Journal of Clinical Gastroenterology. 48:290-299
The aim of this study was to explore whether prophylactic use of transjugular intrahepatic portosystemic shunt (TIPS) could aid in the treatment of refractory ascites on the basis of current randomized controlled trials.TIPS is more effective for ref